Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Leukemia Research|May 17, 2005
A proapoptotic function of p21 in differentiating granulocytesLouis Ghanem, Richard SteinmanBritish Journal of Haematology|January 14, 2004
Cdk-inhibitors and exit from quiescence in primitive haematopoietic cell subsetsRichard Steinman, Beatrice Yaroslavskiy, Julie P Goff, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|May 9, 2015
Using software to elicit user needs for clinical research visit schedulingChunhua Weng, Mary Regina Boland, Yat So, et al.Heart Rhythm|October 31, 2012
Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trialsDemosthenes G Katritsis, Konstantinos C Siontis, J Thomas Bigger, et al.Psychosomatic Medicine|December 24, 2009
Cardiac autonomic control and treatment of hostility: a randomized controlled trialRichard P Sloan, Peter A Shapiro, Ethan E Gorenstein, et al.American Heart Journal|October 8, 2013
A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratificationFaisal M Merchant, Hui Zheng, Thomas Bigger, et al.Shock (Augusta, Ga.)|January 20, 2023
MACROPHAGE SWITCHING: POLARIZATION AND MOBILIZATION AFTER TRAUMALara Hoteit, Patricia Loughran, Shannon Haldeman, et al.Circulation. Cardiovascular Quality and Outcomes|February 12, 2015
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trialsPaul L Hess, Sana M Al-Khatib, Joo Y Han, et al.JACC. Heart Failure|October 13, 2014
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trialsBenjamin A Steinberg, Sana M Al-Khatib, Rex Edwards, et al.American Heart Journal|September 11, 2017
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trialsDaniel J Friedman, Sana M Al-Khatib, Emily P Zeitler, et al.Pageof 2